Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,194,910
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
2,360,259
-
Shares change
-
+543,874
-
Total reported value, excl. options
-
$13,310,203
-
Value change
-
+$3,384,583
-
Number of buys
-
19
-
Number of sells
-
16
-
Price
-
$5.64
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q2 2024
As of 30 Jun 2024 Journey Medical Corp - Common Stock (DERM) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,360,259 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Cambridge Investment Research Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, PVG ASSET MANAGEMENT CORP, TANG CAPITAL MANAGEMENT LLC, ENVESTNET ASSET MANAGEMENT INC, Rosalind Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This table shows 35 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.